¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"middle latency response"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® middle ear ÇÑ±Û °¡¿îµ¥±Í, ÁßÀÌ
¼³¸í   
  ±Í´Â ¹Ù±ùÀÇ ¹Ù±ù±Í, ±×¸®°í À½À» Àü´ÞÇϴ °¡¿îµ¥±Í, Àü´ÞµÈ À½À» ½Å°æÀÌ ¾Ë¾ÆµéÀ» ¼ö ÀÖµµ·Ï ¹Ù²ãÁִ ±â´ÉÀÇ ¼Ó±Í, ÀÌ 3°¡Áö·Î ±¸ºÐµÇ¾î Áø´Ù. °¡¿îµ¥±Í´Â °í¸·¿¡¼­ºÎÅÍ ¼Ó±Í±îÁö ¿¬°áµÇ´Â °÷±îÁöÀε¥ ¿©±â¿¡ 3°¡ÁöÀÇ Á¶±×¸¶ÇÑ »À°¡ ÀÖ¾î °í¸·¿¡ ¿ï¸° À½ÀÌ ¼Ó±Í±îÁö ÀüÇØÁöµµ·Ï ÇØÁØ´Ù. À̶§ ÀÌ »Àµé°ú °í¸·ÀÇ ÀÛ¿ëÀ¸·Î ±Í¿¡ µé¸° À½Àº ¾à 21¹èÁ¤µµÀÇ È®´ëÈ¿°ú°¡ ³ªÅ¸³­´Ù. ¼Ó±Í´Â ÀÌ·¸°Ô Çؼ­ ÀüÇØÁø À½À» ÄÚ¸£Æ¼ ±â°ü¿¡ ÀÇÇØ¼­ ½Å°æÀÌ ¾Ë¾Æ µéÀ» ¼ö Àִ ½ÅÈ£ Àü´Þü°è·Î ¹Ù²Ù¾î ³ú¿¡ ÀüÇØÁִ ¿ªÇÒÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • middle latency response
    Áß°£Àẹ¹ÝÀÀ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • latency
    1. ÀáÀç±â, Àẹ±â 2. Àá½Ã
  • motor latency
    ¿îµ¿½Å°æÀá½Ã
  • multiple sleep latency test
    ¼ö¸éÀẹ±â¹Ýº¹°Ë»ç
  • proximal latency
    ±ÙÀ§Àẹ±â, ¸öÂÊÀẹ±â
  • REM latency
    ·½Àẹ±â, ·½¼ö¸éÀẹ±â
  • residual latency
    ÀÜ·ùÀẹ, ÀÜ·ùÀá½Ã
  • sensory latency
    °¨°¢½Å°æÀá½Ã
  • sensory peak latency
    °¨°¢½Å°æÁ¤Á¡Àá½Ã
  • sleep latency
    ¼ö¸éÀẹ±â
  • middle
    Áß°£-
  • middle age
    Áß³â
  • middle cerebellar peduncle
    Áß°£¼Ò³ú´Ù¸®, Áß¼Ò³ú°¢
  • middle cerebral artery
    Áß°£´ë³úµ¿¸Æ, Áß´ë³úµ¿¸Æ
  • middle clunial nerve
    Áß°£º¼±â½Å°æ, ÁߵнŰæ
  • middle colic artery
    Áß°£Àß·ÏâÀÚµ¿¸Æ, Áß°áÀ嵿¸Æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • latency
    1. ÀáÀç±â, Àẹ±â, 2. Àá½Ã
  • sleep latency
    ¼ö¸éÀẹ±â
  • middle age
    Áß³â
  • middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
  • middle ear
    °¡¿îµ¥±Í, ÁßÀÌ
  • middle finger
    °¡¿îµ¥¼Õ°¡¶ô
  • middle
    Áß°£-
  • middle phalanx
    Áß°£¸¶µð»À
  • response curve
    ¹ÝÀÀ°î¼±
  • response decline
    ¹ÝÀÀ°¨¼Ò
  • response
    ¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • late asthmatic response
    ¸¸±âõ½Ä¹ÝÀÀ, Èıâõ½Ä¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • middle age
    Áß³â
  • middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
  • middle collateral artery
    Áß°£°çµ¿¸Æ
  • bulbocavernous reflex latency test
    ¸Á¿ïÇØ¸éü±Ù¹Ý»ç½Ã°£ÃøÁ¤°Ë»ç
  • middle ear
    °¡¿îµ¥±Í, ÁßÀÌ
  • middle finger
    °¡¿îµ¥¼Õ°¡¶ô
  • middle cranial fossa
    Áß°£¸Ó¸®¿ì¹¬, Áߵΰ³¿Í
  • latency
    Àẹ±â
  • motor latency
    ¿îµ¿½Å°æÀá½Ã
  • proximal latency
    ±ÙÀ§Àá½Ã
  • REM latency
    ·½Àẹ±â, ·½¼ö¸éÀẹ±â
  • residual latency
    ÀÜ·ùÀẹ
  • sensory latency
    °¨°¢½Å°æÀá½Ã
  • sensory peak latency
    °¨°¢½Å°æÁ¤Á¡Àá½Ã
  • sleep latency
    ¼ö¸éÀẹ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • REM latency
    ·½Àẹ±â
  • herpes virus,latency
    Àẹ¼º
  • MES=£¾middle extrosylvian gyrus
    Á߿ܽǺñ¿ì½º³úȸ.
  • Middle brook medum
    ¹Ìµéºê·è¹èÁö
  • anastomotic branch (with middle meningeal artery)
    ¿¬°á°¡Áö (Áß°£³ú¸·µ¿¸Æ°úÀÇ)
  • artery, middle meningeal
    Á߰渷µ¿¸Æ, Áß°£³ú¸·µ¿¸Æ{ÇØ}
  • ganglion, middle cervical
    Áß°æ½Å°æÀý, Áß°£¸ñ½Å°æÀý
  • radical operation of middle ear
    ÁßÀ̱ÙÄ¡¼ö¼ú
  • BERA =Brainstem Evoked Response Audiometry
    ³ú°£À¯¹ß¹ÝÀÀû·Â°Ë»ç
  • Fast response
    ±Þ¼Ó(ÐááÜ)¹ÝÀÀ(Úãëë)
  • Inflammatory response
    ¿°Áõ¹ÝÀÀ(æúñøÚãëë)
  • Lewis triple response
    ·çÀ̽º »ïÁß ¹ÝÀÀ
  • MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
    ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
  • allergic response
    ¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
  • analytical response detection
    ºÐ¼®¹ÝÀÀ°¨Áö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bulbocavernous reflex latency test
    ±¸Çظéü ¹Ý»ç½Ã°£ ÃøÁ¤°Ë»ç
  • herpes virus,latency
    Àẹ¼º
  • latency
    Àẹ±â
  • latency period
    ÀáÀç±â, ÀáÀ翬·É±â, Àẹ ±â°£.
  • latency period
    Àẹ±â
  • latency period
    ÀáÀç±â, ÀáÀ翬·É±â, Àẹ±â°£.
  • latency, bulbocavernous reflex (BCRL)
    ±¸Çظéü±Ù¹Ý»ç Àẹ±â
  • multiple sleep latency test ( MSLT )
    ¼ö¸éÀẹ±â ¹Ýº¹°Ë»ç
  • sleep latency
    ¼ö¸éÀẹ±â
  • stage of latency
    Àẹ±â(íÖÜÑÑ¢).
  • stage of latency
    Àẹ±â(íÖÜÑÑ¢)
  • age-response function
    ¿¬·É¹ÝÀÀÇÔ¼ö
  • alerting response
    °¢¼º¹ÝÀÀ(ÊÆá¥Úãëë)
  • allergic response
    ¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
  • analytical response detection
    ºÐ¼®¹ÝÀÀ°¨Áö
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Meningeal branch (Middle meningeal branch)
    (Áß°£)³ú¸·°¡Áö
    [¿¾ ¿ë¾î] (Áß)°æ¸·Áö
  • Middle ear
    °¡¿îµ¥±Í [ÁßÀÌ]
    [¿¾ ¿ë¾î] ÁßÀÌ
  • Deep middle cerebral vein
    ±íÀºÁß°£´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÉÁß´ë³úÁ¤¸Æ
  • Middle frontal gyrus
    ¾ÈÂÊÀ̸¶À̶û
    [¿¾ ¿ë¾î] ³»ÃøÀüµÎȸ
  • Superficial middle cerebral vein
    ¾èÀºÁß°£´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] õÁß´ë³úÁ¤¸Æ
  • Anastomotic branch (with middle meningeal artery)
    ¿¬°á°¡Áö (Áß°£³ú¸·µ¿¸Æ°úÀÇ)
    [¿¾ ¿ë¾î] ¹®ÇÕÁö
  • Right middle lobar bronchus
    ¿À¸¥Áß°£¿±±â°üÁö
    [¿¾ ¿ë¾î] ¿ìÁß¿±±â°üÁö
  • Middle collateral artery
    Áß°£°çµ¿¸Æ
    [¿¾ ¿ë¾î] ÁßÃøºÎµ¿¸Æ
  • Middle rectal artery
    Áß°£°ðâÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÁßÁ÷À嵿¸Æ
  • Middle rectal plexus
    Áß°£°ðâÀڽŰæ¾ó±â
    [¿¾ ¿ë¾î] ÁßÁ÷À嵿¸Æ½Å°æÃÑ
  • Middle rectal veins
    Áß°£°ðâÀÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁßÁ÷ÀåÁ¤¸Æ
  • Middle temporal artery
    Áß°£°üÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÁßÃøµÎµ¿¸Æ
  • Groove for middle temporal artery
    Áß°£°üÀÚµ¿¸Æ°í¶û
    [¿¾ ¿ë¾î] ÁßÃøµÎµ¿¸Æ±¸
  • Middle temporal branches
    Áß°£°üÀÚ¿±°¡Áö
    [¿¾ ¿ë¾î] ÁßÃøµÎÁö
  • Middle temporal artery
    Áß°£°üÀÚ¿±µ¿¸Æ
    [¿¾ ¿ë¾î] ÁßÃøµÎµ¿¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • latency
    Àẹ(íÖÜÑ)
  • middle-repetitive DNA
    Áßµî¹Ýº¹(ñéÔõÚãÜÖ) DNA
  • adaptive response
    ÀûÀÀÀû ´ëÀÀ(îêëëîÜÓßëë)
  • anamnestic response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ(ì£ó­Øóæ¹Úãëë)
  • anaphylactic response
    ¾Æ³ªÇʶô½Ã½º ´ëÀÀ(Óßëë)
  • antibody response
    Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
  • autoimmune response
    ÀÚ°¡¸é¿ª´ëÀÀ (í»Ê«Øóæ¹Óßëë)
  • biological response modifier
    »ý¹°ÇÐÀû ´ëÀÀ¼ö½ÄÀÚ(ßæÚªùÊîÜÓßëëáóãÞí­)
  • booster response
    ºÎ½ºÅÍ ´ëÀÀ(Óßëë)
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • heat shock response
    ¿­(æð)
  • immune response
    ¸é¿ª ´ëÀÀ(Øóæ¹Óßëë)
  • immune response gene
    ¸é¿ª ´ëÀÀ À¯ÀüÀÚ(Øóæ¹Óßëëë¶îîí­)
  • lysogenic response
    ¿ë¿ø´ëÀÀ(éÁê«Óßëë)
  • lytic response
    ¿ëÇØ´ëÀÀ(éÁú°Óßëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • latency
    Àẹ, ÀáÀç
  • response
    ¹ÝÀÀ, ÀÀ´äÀÇ
  • response frequency
    ¹ÝÀÀÁ֯ļö
  • middle
    Áß¾ÓÀÇ
  • middle cerebellar peduncle
    Áß¼Ò³ú°¢
  • middle cerebral artery
    Áß´ëÁ˵¿¸Æ
  • middle colic artery
    Áß°£°áÀ嵿¸Æ, Áß°áÀ嵿¸Æ
  • middle cranial fossa
    Áß°£µÎ°³¿ì¹¬, Áߵΰ³¿Í
  • middle density
    Áß°£À½¿µ, Áß°£¹Ðµµ
  • middle ear
    ÁßÀÌ
  • middle genicular artery
    Áß°£¹«¸­µ¿¸Æ, Áß½½µ¿¸Æ
  • middle lobe
    Áß°£¿±, Áß¿±
  • middle lobe syndrome
    Áß¿±ÁõÈıº
  • middle lung field
    Á߯ó¾ß
  • middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ, Á߰渷µ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MLR mean length response; middle latency response; mixed lymphocyte reaction
ML Licentiate in Medicine; Licentiate in Midwifery; malignant lymphoma; marked latency; maximum likelih...
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MLR Middle Latency Response
MLAEP Middle Latency Auditory Evoked Potential
MAEP Middle latency auditory evoked potentials
LAP 1-latency associated peptide
DML Distal Motor Latency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • latency
    Àẹ, ÀáÀç, ÀáÀç±â
    ¹«È°µ¿À̶ó°í »ý°¢µÇ´Â »óÅ·Î, ÀÚ±ØÀÇ ½Ã°£ºÎÅÍ ¹ÝÀÀ °³½Ã »çÀÌÀÇ ½Ã°£.
  • latency phase
    Àẹ±â
    º´¼Ò°¡ ħÀÔÇØ¼­ Áï½Ã °¨¿°À» ÀÏÀ¸Å°´Â °ÍÀÌ ¾Æ´Ï°í ¼÷ÁÖ ³»¿¡ ±â»ýÇϸ鼭 ÀûÀÀÇØ¼­ °¨¿°ÀÇ Áõ»óÀ» ³ªÅ¸³»±â±îÁöÀÇ ½Ã°£.
  • stage of latency
    Àẹ±â
    º´¿ø ¹Ì»ý¹°ÀÌ »ç¶÷ ¶Ç´Â µ¿¹°ÀÇ Ã¼³»¿¡ ħÀÔÇÏ¿© ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. Àẹ±â°¡ »ý±â´Â ÀÌÀ¯´Â º´¿ø ¹Ì»ý¹°ÀÇ Á¾·ù¿¡ µû¶ó ÀÏÁ¤ÇÏÁö´Â ¾Ê´Ù. ¿¹¸¦ µé¸é, ¸»¶ó¸®¾Æ¿Í °°ÀÌ Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ Á¤µµ±îÁö ¹ßÀ°ÇÑ ´ÙÀ½ ¹ßº´ÇÏ´Â °Í, ÀåÆ¼Çª½º¿Í °°ÀÌ Ã¼³»¿¡¼­ ±ÕÀÌ ÀÏÁ¤ ¼ö±îÁö ¹ø½ÄÀ» ÇØ¾ß ¹ßº´ÇÏ´Â °Í, ÆÄ»ódz°ú °°ÀÌ ±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú ½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡¾ß ¹ßº´ÇÏ´Â °Í µîÀÌ ÀÖ´Ù. µû¶ó¼­ Àẹ ±â°£Àº Áúº´¿¡ µû¶ó °ÅÀÇ ÀÏÁ¤ÇÑ °Í°ú, »ó´çÈ÷ Àå´ÜÀÇ ÆøÀÌ Å« °Í µîÀÌ ÀÖ´Ù. ¶Ç, µ¿ÀÏ Áúȯ¿¡¼­µµ ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾ç, µ¶·Â ¹× ħÀÔ ´çÇÑ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ¿µÇâÀ» ¹Þ´Â´Ù. Àẹ ±â°£¿¡´Â ÀϹÝÀûÀ¸·Î º´Àû ¡Èĸ¦ ³ªÅ¸³»Áö ¾ÊÀ¸³ª, ¹Î°¨ÇÑ »ç¶÷Àº µÎÁß, ½Ä¿å ºÎÁø, Çö±âÁõ, ºÒÄè°¨ µîÀ» ´À³¢´Â ¼öµµ ÀÖ´Ù. À̰ÍÀ» Àü±¸ Áõ¼¼¶ó°í ÇÑ´Ù. ¶Ç, Á¶½ÉÇØ¾ß ÇÒ Á¡Àº Àẹ±â¿¡µµ º´¿øÃ¼¸¦ ¹èÃâÇÏ´Â À§ÇèÀÌ ÀÖ´Â Á¡, ÆÄ»ódzÀ̳ª ±¤°ßº´°ú °°ÀÌ ¹ßº´ÀÌ µÈ ÈÄ¿¡´Â Ä¡À¯°¡ °ï¶õÇϹǷΠÀẹ±â Áß¿¡ ¹ßº´ÀÇ ¿¹¹æÀûÀÎ Ä¡·á¸¦ ÇÏÁö ¾ÊÀ¸¸é ¾È µÇ´Â ÁúȯÀÌ ÀÖ´Ù´Â Á¡, È«¿ª°ú °°ÀÌ Àẹ±â¸¦ ÀÌ¿ëÇÏ¿© ¥ã±Û·ÎºÒ¸° ¿¹¹æ Áֻ縦 ³õ¾Æ °¡º±°Ô ¹ßº´½ÃÄÑ ¸é¿ªÀ» ¸¸µé°Ô ÇÏ¸é µÇ´Â º´µµ ÀÖ´Ù´Â Á¡ÀÌ´Ù.
  • late middle age
    Àå³â±â
    40´ë ÈĹݿ¡¼­ 50´ë ÈĹݱîÁöÀÇ ³ªÀÌ.
  • middle age
    Áß³â
  • middle cerebellar peduncle syndrome
    Áß ¼Ò³ú °¢ ÁõÈıº
  • middle cervical ganglion
    Áß°£¸ñ ½Å°æÀý, Áß°æ½Å°æÀý
  • middle coat
    Á߸·
  • middle colic vein
    Áß°£ ÁÖ¸§ âÀÚ Á¤¸Æ
  • middle concha
    Áß°£ ºñ°©°³, Áߺñ°©°³
  • middle cranial fossa
    Áß°£ µÎ °³ ¿ì¹¬, Áߵΰ³¿Í
  • middle ear
    ÁßÀÌ
    °í¸·ÀÇ ³»Ãø °ø°£À¸·Î¼­ À̼ҰñÀ» Æ÷ÇÔÇÑ °í½Ç·Î Çü¼ºµÇ°í, À¯¾ç µ¹±â ºÀ¼Ò¿Í À̰üÀ¸·Î ¿¬¶ôµÈ´Ù.
  • middle ear neoplasia
    ÁßÀÌÀÇ ½Å»ý¹°
    ÁßÀÌ¿¡ ÀÏÂ÷ÀûÀ¸·Î ¹ß»ýÇÏ´Â Á¾¾çÀº µå¹°´Ù. »ç±¸Á¾¾ç
  • middle ear prosthesis
    ÁßÀÌ º¸Ã¶
  • middle genicular artery
    Áß°£ ¹«¸­ µ¿¸Æ, Áß½½µ¿¸Æ
    ±â¿øÀº ½½¿Íµ¿¸Æ. ºÐÁö´Â ¾øÀ½. ºÐÆ÷´Â ½½°üÀý, ½ÊÀÚÀδë, Ȱ¸·, ÀÍ»óÁÖ¸§.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
virus latency The ability of a pathogenic virus to lie dormant within a cell (latent infection). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors.
(12 Dec 1998)
multiple sleep latency test A test of the propensity to fall asleep, done by performing polysomnography during multiple brief opportunities to sleep.
(05 Mar 2000)
latency 1. <physiology> The time between onset of a stimulus and peak of the ensuing action potential.
2. <microbiology> Of an infection, a period in which the infection is present in the host without producing overt symptoms.
(18 Nov 1997)
latency period <psychology> The period from about 5 to 7 years to adolescence when there is an apparent cessation of psychosexual development.
(12 Dec 1998)
latency phase In psychoanalytic personality theory, the period of psychosexual development in children, extending from about age 5 to the beginning of adolescence at age 12, during which the apparent cessation of sexual preoccupation during this period stems from a strong, aggressive blockade of libidinal and sexual impulses in an effort to avoid oedipal relationships; during this phase, boys and girls are inclined to choose friends and join groups of their own sex.
Synonym: latency period.
(05 Mar 2000)
anamnestic response <immunology> Archaic term now replaced by such terms as secondary immune response, immune memory.
(18 Nov 1997)
audiometry, evoked response A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.
(12 Dec 1998)
auditory brainstem response audiometry An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli.
(05 Mar 2000)
biological response modifier <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour.
(16 Dec 1997)
biological response modifiers Substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts and use them in cancer treatment. Also called BRMs.
(12 Dec 1998)
biphasic response Two separate and distinct responses that are separated in time, immediate reaction to an antigenic challenge followed by a recurrence of symptoms after an interval of quiescence.
(05 Mar 2000)
booster response The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen.
(18 Nov 1997)
brainstem evoked response audiometry An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli.
(05 Mar 2000)
galvanic skin response A change in electrical resistance of the skin, occurring in emotion and in certain other conditions.
(12 Dec 1998)
recruiting response <neurology> The gradual increase to a maximum in a reflex when a stimulus of unaltered intensity is prolonged.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • latency
    ¼û¾î ÀÖÀ½;º¸ÀÌÁö ¾ÊÀ½;Àẹ;ÀáÀç
  • response
    ÀÀ´ä
  • conditioned reflex (response)
    Á¶°Ç ¹Ý»ç
  • flexible response
    ½ÅÃàÀû ´ëÀÀ(1967³â NOTO°¡ ¹Ù¸£»þ¹Ù Á¶¾à±º¿¡ ´ëÇØ¼­ äåÇÑ Àü·«)
  • flexible response
    ½ÅÃàÀû´ëÀÀ
  • frequency response
    Á֯ļöÀÀ´ä
  • galvanic skin response
    Àü±â ÇǺΠ¹ÝÀÀ(°ÅÁþ¸» ŽÁö±â¿¡ ÀÀ¿ë)
  • immune response
    ¸é¿ª ÀÀ´ä;¸é¿ª ¹ÝÀÀ
  • reader-response criticism
    µ¶ÀÚ ¹ÝÀÀÀÇ ºñÆò(reader-oriented criticismÀÇ ÀÏÁ¾)
  • response
    ÀÀ´ä;´ë´ä(answer,reply);°¨ÀÀ;¹ÝÀÀ;(ÀÚ±Ø(stimulus)¿¡ ´ëÇÑ )¹ÝÀÀ;ÀÀ´ä¹®(°¡);ÀÀâ(»çÁ¦¸¦ µû¶ó ÇÕâ´ë.½ÅµµµéÀÌ Ã¢È­ÇÏ´Â);(ºê¸®Áö¿¡¼­ÀÇ)¸®½ºÆù½º
  • response curve
    (¸¶ÀÌÅ©·ÎÆùµîÀÇ)ÀÀ´ä °î¼±
  • response time
    ÀÀ´ä ½Ã°£
  • uncondltioned response
    ¹«Á¶°Ç¹Ý»ç
  • middle
    ÇÑ °¡¿îµ¥ÀÇ,°¡¿îµ¥
  • Middle Dutch
    Áß¼¼(Áß±â) ³×´ú¶õµå ¸»
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á